The Food and Drug Administration (FDA) inspected Arthrosurface, Inc. in West Bridgewater on April 1, based on information available on the FDA’s website.
The inspection’s final report advised Arthrosurface, Inc. to address operational management concerns related to device compliance. No corrective action was found necessary for other reviewed areas.
The FDA conducts regular inspections of facilities across the United States to evaluate whether both workplaces and products meet requirements under FDA-regulated laws aimed at safeguarding public health. Results from these inspections are released publicly.
The agency’s website states that the FDA is responsible for overseeing the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.
Information for this article comes from the U.S. Food and Drug Administration. The original data is available here.
